| Medical Mutual | Vyvgart Hytrulo ® (efgartigimod alfa-fcab and | 2025-11-20 |
| Medical Mutual | Vyvgart ® (efgartigimod alfa-fcab) (Intraveous) | 2025-11-20 |
| Medical Mutual | Yescarta ® (axicabtagene ciloleucel) suspension for | 2025-11-20 |
| Medicare CGS | Billing and Coding: Outpatient Physical and Occupational Therapy Services (57067) | 2025-11-20 |
| Aetna | Comparative Genomic Hybridization (CGH) | 2025-11-19 |
| Aetna | Alzheimer's Disease: Experimental, Investigational, or Unproven Treatments | 2025-11-19 |
| Aetna | Acute Ischemic Stroke Treatments | 2025-11-19 |
| Aetna | Near-Infrared (NIR) Spectroscopy | 2025-11-19 |
| Aetna | Management of Meibomian Glands | 2025-11-19 |
| Aetna | Blood and Adipose Tissue Derived Products for Selected Indications | 2025-11-19 |